Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

Clinical trial NCT06756022 · RECRUITING

Trial details

NCT number: NCT06756022
Sponsor: Anhui Provincial Children's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Chemotherapy Induced Nausea and Vomiting

Start date: 2024-11-21
Primary completion: 2025-12-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.